Applied Biosystems and Spanish bioinformatics shop Integromics have revisited an existing collaboration to develop a software system for analyzing real-time PCR data, the firms said this week.
The system, called Real-Time StatMiner, will combine Integromics’ statistical-analysis software with ABI’s real-time PCR instrument systems. The companies will co-market the product.
This is the second partnership for the pair: the companies allied two years ago when Integromics developed analysis tools for ABI’s microarray platform. Integromics, based in Granada, specializes in software for managing and analyzing microarray data, and also offers text-mining analysis tools.
This week, ABI said in a statement that the combined product will be designed to support the growing field of new applications for real-time PCR, including gene-expression analysis, stem-cell differentiation, and microRNA analysis.
The company said that many customers currently develop their own software for these applications but that these are “only loosely integrated with their systems, requiring bioinformatics expertise to manage them.”
ABI said that Real-Time StatMiner will be the first time researchers can buy a product that integrates the system that generates the data with the software that analyzes it.
Integromics’ commercial director, Imad Yassin, told BioInform via e-mail this week that the new solution is already in place “in many of the top 20 pharma sites” and the company has received positive feedback so far.
Yassin said that Integromics and ABI also plan to “develop this product further to address strong areas of interest like biomarker discovery.”
The solution will integrate StatMiner with any combination of ABI’s real-time PCR systems and provides interactive data visualization, statistical analysis, and data-mining capabilities, ABI said.
The StatMiner software will also be a standalone application and will be available as an “integrated guide within other data-analysis systems,” ABI said.
Integromics will also offer a version of Real-Time StatMiner that is integrated with Spotfire’s DecisionSite software and Functional Genomics packages.
Yassin said that current market data shows an increase in the use of real-time PCR technology, and with its application to new approaches such as miRNA analysis, “we only expect it to keep growing.”
He added that he hopes the two companies continue to “extend our collaboration” to “address other areas of common interest.”
It was not immediately clear whether ABI shopped around before renewing its collaboration with Integromics. ABI officials were unavailable for comment before deadline.